Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01024478
Recruitment Status : Completed
First Posted : December 2, 2009
Last Update Posted : July 7, 2011
Sponsor:
Collaborators:
Fujian Medical University Union Hospital
Air Force Military Medical University, China
Huazhong University of Science and Technology
Nanjing Medical University
First Affiliated Hospital, Sun Yat-Sen University
Henan Provincial People's Hospital
Fudan University
Information provided by:
Capital Medical University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The multicenter study evaluates the diagnostic performance of 3.0 T contrast-enhanced whole-heart coronary MRA in patients with suspected coronary artery disease.

Condition or disease
Coronary Artery Disease

Detailed Description:

This is a multicenter trial evaluated the diagnostic ability of 3.0 T contrast-enhanced whole-heart coronary MRA to detect significant coronary artery stenosis among patients with suspected CAD.

A total of 272 patients will be prospectively enrolled from 8 cities in China.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 272 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial
Study Start Date : October 2009
Actual Primary Completion Date : September 2010
Actual Study Completion Date : September 2010

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Consecutive eligible patients scheduled to undergo conventional coronary angiography.
Criteria

Inclusion Criteria:

  • Suspected CAD, scheduled for DSA
  • Sinus rhythm

Exclusion Criteria:

  • Contraindications to MR examination: pacemaker, intraauricular implants, intracranial clips, thoracotomy, claustrophobia, orthopnea
  • Acute coronary syndrome
  • Atria fibrillation
  • Coronary stents
  • Bypass grafts
  • Renal insufficiency (estimated glomerular filtration rate assessed by creatinine clearance <60 ml/min/1.73 m2)
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01024478


Locations
Layout table for location information
China, Beijing
Radiology Department of Xuanwu Hopital
Beijing, Beijing, China, 100053
Sponsors and Collaborators
Capital Medical University
Fujian Medical University Union Hospital
Air Force Military Medical University, China
Huazhong University of Science and Technology
Nanjing Medical University
First Affiliated Hospital, Sun Yat-Sen University
Henan Provincial People's Hospital
Fudan University
Investigators
Layout table for investigator information
Principal Investigator: kuncheng li, M.D. Xuanwu Hospital, Beijing
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: Li,kuncheng, Radiology department of Xuanwu Hospital
ClinicalTrials.gov Identifier: NCT01024478    
Other Study ID Numbers: CapitalMedicalU
First Posted: December 2, 2009    Key Record Dates
Last Update Posted: July 7, 2011
Last Verified: December 2009
Keywords provided by Capital Medical University:
Coronary Artery
Magnetic Resonance Angiography
Coronary Artery disease
Multicenter Trial
Cardiac MRI
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases